MC
BIIB icon

Muhlenkamp & Co’s Biogen BIIB Stock Holding History

Muhlenkamp & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,218
Closed -$6.31M – 33
2021
Q2 		$6.31M Buy
18,218
+34
+0.2% +$10.3K 2.31% 25
2021
Q1 		$6.36M Buy
18,184
+37
+0.2% +$9.98K 2.35% 24
2020
Q4 		$4.44M Buy
18,147
+94
+0.5% +$24.2K 1.79% 26
2020
Q3 		$5.12M Buy
18,053
+222
+1% +$61.9K 2.65% 20
2020
Q2 		$4.77M Buy
+17,831
New +$5.36M 2.55% 20
2019
Q4 		$5.27M Sell
17,768
-6
-0% -$1.67K 2.3% 22
2019
Q3 		$4.14M Sell
17,774
-6
-0% -$1.4K 2.02% 25
2019
Q2 		$4.16M Sell
17,780
-63
-0.4% -$14.5K 2.02% 23
2019
Q1 		$4.22M Buy
+17,843
New +$5.62M 2% 23
2018
Q3 		$6.49M Sell
18,368
-6,803
-27% -$2.34M 2.78% 18
2018
Q2 		$7.31M Hold
25,171
– – 2.79% 17
2018
Q1 		$6.89M Buy
25,171
+489
+2% +$152K 2.5% 21
2017
Q4 		$7.86M Buy
24,682
+135
+0.5% +$43.3K 2.32% 18
2017
Q3 		$7.69M Sell
24,547
-998
-4% -$296K 2.42% 20
2017
Q2 		$6.93M Sell
25,545
-12
-0% -$3.17K 2.17% 21
2017
Q1 		$6.99M Buy
25,557
+2,278
+10% +$644K 2.14% 22
2016
Q4 		$6.6M Sell
23,279
-199
-0.8% -$59K 2.08% 20
2016
Q3 		$7.35M Sell
23,478
-225
-0.9% -$66.6K 2.78% 17
2016
Q2 		$5.73M Sell
23,703
-150
-0.6% -$39.5K 2.24% 19
2016
Q1 		$6.21M Buy
+23,853
New +$6.3M 2.53% 19

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Muhlenkamp & Co's BIIB Position: Q3 2021 in Review

Muhlenkamp & Co sold out of Biogen (BIIB) in Q3 2021, closing a stake of 18,218 shares — an estimated $6.31M sold.

Muhlenkamp & Co first reported a position in BIIB in Q1 2016 and held it in 20 quarters. The position peaked at $7.86M in Q4 2017. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Muhlenkamp & Co reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Muhlenkamp & Co sold 18,218 Biogen shares in Q3 2021, an estimated $6.31M.
  • Muhlenkamp & Co first reported a position in Biogen in Q1 2016 and held it in 20 quarters.
  • Muhlenkamp & Co's Biogen position peaked at $7.86M in Q4 2017.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Muhlenkamp & Co's 13F filing for Q3 2021, filed 10 Dec 2021.